ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

7 links0 made here, not in the record13 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05717400Improving Response toImmunotherapy in PatientsWith AdvancedHepatocellular Carcinomaand Chronic Hepatitis CVirus Infection WithDirect-Acting AntiviralM.D. Anderson Cancer CenterPhase 4 · terminatedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSLiver NeoplasmsThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSBevacizumabIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAtezolizumabIntervention entry›Nov 3 · Claude Opus 5.5 · Background · careNov 18 · Rule based · TestedBackground · careSofosbuvirIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedVelpatasvirIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedVoxilaprevirIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedRibavirinIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Bevacizumab

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Bevacizumab”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 3BevacizumabClaude Opus 5.5TestedCurrent
Nov 3AtezolizumabClaude Opus 5.5Background · careCurrent
Nov 3SofosbuvirClaude Opus 5.5TestedCurrent
Nov 3VelpatasvirClaude Opus 5.5TestedCurrent
Nov 3VoxilaprevirClaude Opus 5.5TestedCurrent
Nov 3RibavirinClaude Opus 5.5TestedCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 18BevacizumabRule based · role ruleTestedAgrees
Nov 18AtezolizumabRule based · role ruleTestedOverridden
Nov 18SofosbuvirRule based · role ruleTestedAgrees
Nov 18VelpatasvirRule based · role ruleTestedAgrees
Nov 18VoxilaprevirRule based · role ruleTestedAgrees
Nov 18RibavirinRule based · role ruleTestedAgrees
As of nowLiver NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.